BISACODYL SUPPOSITORIES

N/A

Manufactured by Oncor Pharmaceuticals

38,233 FDA adverse event reports analyzed

Last updated: 2026-04-14

About BISACODYL SUPPOSITORIES

BISACODYL SUPPOSITORIES is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Oncor Pharmaceuticals. The most commonly reported adverse reactions for BISACODYL SUPPOSITORIES include CONSTIPATION, NAUSEA, DRUG INEFFECTIVE, PAIN, OFF LABEL USE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for BISACODYL SUPPOSITORIES.

Top Adverse Reactions

CONSTIPATION1,389 reports
NAUSEA1,259 reports
DRUG INEFFECTIVE1,250 reports
PAIN1,054 reports
OFF LABEL USE1,050 reports
VOMITING912 reports
FALL796 reports
DYSPNOEA782 reports
MACULAR DEGENERATION770 reports
PNEUMONIA746 reports
PYREXIA726 reports
ABDOMINAL PAIN719 reports
DEATH716 reports
FATIGUE673 reports
HYPOTENSION660 reports
ANAEMIA652 reports
HEADACHE608 reports
ASTHENIA560 reports
CONDITION AGGRAVATED557 reports
DIARRHOEA549 reports
MALAISE498 reports
WEIGHT DECREASED482 reports
ACUTE KIDNEY INJURY444 reports
BALANCE DISORDER439 reports
COGNITIVE DISORDER436 reports
SEPSIS432 reports
GENERAL PHYSICAL HEALTH DETERIORATION427 reports
TOXICITY TO VARIOUS AGENTS412 reports
ORTHOSTATIC HYPOTENSION390 reports
MOBILITY DECREASED359 reports
URINARY TRACT INFECTION357 reports
OEDEMA PERIPHERAL354 reports
DIZZINESS351 reports
RENAL FAILURE351 reports
HYPONATRAEMIA349 reports
ABDOMINAL DISTENSION346 reports
SEDATION345 reports
SOMNOLENCE343 reports
CHRONIC KIDNEY DISEASE338 reports
PRODUCT USE IN UNAPPROVED INDICATION337 reports
DEPRESSED LEVEL OF CONSCIOUSNESS327 reports
DRUG INTERACTION309 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE297 reports
SEDATION COMPLICATION296 reports
DECREASED APPETITE294 reports
BLOOD CALCIUM DECREASED293 reports
DYSPEPSIA290 reports
CREATININE RENAL CLEARANCE DECREASED276 reports
COUGH271 reports
ERYTHEMA269 reports
ANXIETY267 reports
INFUSION RELATED REACTION267 reports
CHRONIC OBSTRUCTIVE PULMONARY DISEASE262 reports
CHOLELITHIASIS258 reports
HYPERTENSION256 reports
PULMONARY EMBOLISM253 reports
BACK PAIN251 reports
CHRONIC SINUSITIS250 reports
PAIN IN EXTREMITY247 reports
ASCITES245 reports
CONFUSIONAL STATE245 reports
GASTROOESOPHAGEAL REFLUX DISEASE245 reports
HAEMATOCHEZIA245 reports
RECTAL HAEMORRHAGE243 reports
TREMOR237 reports
DEHYDRATION235 reports
PARAESTHESIA ORAL235 reports
ABDOMINAL PAIN UPPER234 reports
COLITIS232 reports
DRUG HYPERSENSITIVITY232 reports
RASH231 reports
MULTIPLE ORGAN DYSFUNCTION SYNDROME227 reports
PLEURAL EFFUSION226 reports
WHEEZING224 reports
PROCEDURAL PAIN221 reports
SCHIZOPHRENIA220 reports
ARTHRALGIA216 reports
STRESS214 reports
BLOOD CREATININE INCREASED213 reports
FREQUENT BOWEL MOVEMENTS212 reports
PRURITUS212 reports
HYPOXIA211 reports
INTENTIONAL PRODUCT MISUSE205 reports
ORAL CANDIDIASIS204 reports
PRODUCT DOSE OMISSION ISSUE203 reports
BLOOD BILIRUBIN INCREASED201 reports
END STAGE RENAL DISEASE199 reports
CARDIOGENIC SHOCK198 reports
CHEST PAIN198 reports
COLITIS ULCERATIVE198 reports
GAIT DISTURBANCE196 reports
RADICULOPATHY196 reports
FEMALE GENITAL TRACT FISTULA194 reports
INSOMNIA193 reports
PSYCHOTIC DISORDER192 reports
THROMBOSIS192 reports
APPENDICITIS191 reports
DEPRESSION191 reports
PROCTITIS190 reports
HEPATIC ENZYME INCREASED186 reports

Report Outcomes

Out of 12,385 classified reports for BISACODYL SUPPOSITORIES:

Serious 88.4%Non-Serious 11.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female6,421 (56.2%)
Male4,990 (43.7%)
Unknown12 (0.1%)

Reports by Age

Age 77459 reports
Age 80361 reports
Age 71326 reports
Age 52316 reports
Age 65307 reports
Age 69293 reports
Age 72243 reports
Age 68216 reports
Age 78208 reports
Age 70195 reports
Age 76194 reports
Age 75187 reports
Age 64182 reports
Age 62181 reports
Age 66180 reports
Age 73180 reports
Age 67176 reports
Age 58175 reports
Age 61174 reports
Age 74174 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with BISACODYL SUPPOSITORIES?

This profile reflects 38,233 FDA FAERS reports that mention BISACODYL SUPPOSITORIES. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for BISACODYL SUPPOSITORIES?

Frequently reported terms in FAERS include CONSTIPATION, NAUSEA, DRUG INEFFECTIVE, PAIN, OFF LABEL USE, VOMITING. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures BISACODYL SUPPOSITORIES?

Labeling and FAERS entries often list Oncor Pharmaceuticals in connection with BISACODYL SUPPOSITORIES. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.